A Nigerian doctor, Dr. Onyema Ogbuagbu, is at the centre of the Pfizer-led research, development and trials that have culminated in a breakthrough for COVID-19 vaccines.
Pfizer, after the conclusion of its trials, recently announced that its COVID-19 vaccine was more than 90 per cent effective.
A few days after, Moderna also reported that its own version of the COVID-19 vaccine was 94 per cent effective.
The announcement by Pfizer, followed by Moderna, remains a game changer in the quest for COVID-19 vaccine.
Ogbuagbu, however, said he had been involved in the trials of the vaccines by Pfizer
An Associate Professor of Medicine and infectious disease specialist at Yale School of Medicine, Ogbuagbu, in an interview with ABC News, said he was super excited by the results, because having a very effective vaccine would help in achieving the so-called herd immunity.
A 2003 graduate of medicine from the University of Calabar, he noted that currently, there were insufficient doses of the vaccine for everyone at the moment, but contended that enough doses should be available by the first quarter of 2021.
He was of the belief that if a lot of people received the vaccine and were protected against the virus, it would go a long way in containing its spread, which has been ravaging the world since the outbreak of the virus in Wuhan, China.
Pfizer has said it would launch a pilot in four states in the United States, but there have been concerns as the vaccine needed to be stored at -94 degrees Fahrenheit (-70 degree Celsius).…